Evidence map›Paper›PMID 32077755›Full record

ArticleDiabetes technology & therapeutics2020

Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes.

Persis V Commissariat, Amanda L Whitehouse, Marisa E Hilliard, Kellee M Miller, Kara R Harrington, Wendy Levy, Daniel J DeSalvo, Michelle A Van Name, Barbara J Anderson, William V Tamborlane and 2 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes technology & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Social Inequality and Diabetes: A Commentary.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Persis V CommissariatJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Amanda L WhitehouseJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Marisa E HilliardTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Kellee M MillerJaeb Center for Health Research, Tampa, Florida.
Kara R HarringtonJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Wendy LevyTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Daniel J DeSalvoTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Michelle A Van NameYale School of Medicine, Department of Pediatric Endocrinology and Diabetes, New Haven, Connecticut.
Barbara J AndersonTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
William V TamborlaneYale School of Medicine, Department of Pediatric Endocrinology and Diabetes, New Haven, Connecticut.
Linda A DiMeglioDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Baylor College of Medicine · USJoslin Diabetes Center · USYale University · USIndiana University School of MedicineJaeb Center for Health Research · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

There are multiple information sources available to assist families in learning about rapidly advancing diabetes technologies as care options for their children. This study explored where and from whom families of young children with type 1 diabetes get information about diabetes technologies and the valence (positive vs. negative) of that information. Semi-structured interviews were conducted with parents (86% mothers) of 79 youth <8 years old with type 1 diabetes for ≥6 months, ([mean ± standard deviation] age 5.2 ± 1.5 years, diabetes duration 2.4 ± 1.3 years, 77% white, A1c 63 ± 10 mmol/mol [7.9 ± 0.9%], 66% pump-treated, 58% using continuous glucose monitors [CGMs]). Interviews were transcribed and underwent content analysis to derive central themes. Most parents reported learning about new technologies from three direct sources: diabetes care providers, people with diabetes, and caregivers of children with diabetes. Parents also cited three indirect sources of information: online forums, publications, and diabetes-specific conferences. Parents reported hearing primarily positive things about technologies. Families not using pump and/or CGM noted reluctance to use technology due to family-specific concerns (e.g., cost, child's unwillingness to wear device) rather than information from outside sources. In this subset of parents, many still expressed willingness to initiate use once family-specific concerns were resolved. Parents of young children received largely positive information about diabetes technologies, primarily from health care providers and others familiar with using devices personally or for their children. To maximize diabetes technology use in young children, it is incumbent upon providers to ensure families receive balanced realistic information about benefits and barriers.

Indexed as

Diabetes Mellitus, Type 1Insulin Infusion SystemsTechnologyChildChild, PreschoolDecision MakingFemaleHumansHypoglycemic AgentsMaleParentsHypoglycemic AgentsChildContinuous glucose monitorDiabetes mellitusInsulin pumpParentsPerceptionType 1

Identifiers

PMID32077755
PMCPMC7718841
OpenAlexW3007570894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.